Pharmaceutical Antitrust

Global |  Publication |  May 2018

Download Pharmaceutical Antitrust 2018

We have contributed to Getting the Deal Through: Pharmaceutical Antitrust.

Getting the Deal Through is an international publication that provides international expert analysis in key areas of law, practice and regulation for corporate counsel, cross-border legal practitioners, and company directors and officers. Different chapters are written by experts in each area, and Norton Rose Fulbright is proud to present our latest contributions in Pharmaceutical Antitrust 2018.



Contacts

Stephen Nattrass
Stephen Nattrass
Partner
Email
stephen.nattrass@nortonrosefulbright.com
T: +1 613 780 1544
Erin Brown
Erin Brown
Partner
Email
erin.brown@nortonrosefulbright.com
T: +1 613 780 8618

Practice area:

Recent publications

CMMI ushers in new era with WISeR Model

Publication

CMMI ushers in new era with WISeR Model

Certain services covered under traditional Medicare will be subject to prior authorization under a new model from the Center for Medicare and Medicaid Innovation.

United States | July 14, 2025

Healthcare
Texas Law Restricting Acquisition of Real Property Interest by Certain Foreign Individuals and Entities to be Effective September 1, 2025

Publication

Texas law limits foreign ownership of real property

On June 21, 2025, Texas Governor Greg Abbott signed Senate Bill 17 (the Bill) into law, with an effective date of September 1, 2025.

United States | July 11, 2025

Corporate, M&A and securities
Navigating the IPO

Publication

Navigating the IPO

Taking your company public is an important milestone, and whilst the landscape for IPOs is complex and dynamic, choosing the right path is essential.

Global | July 09, 2025

Corporate, M&A and securities
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Subscribe now